Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2017-001297-41Phase 4Active
Phase 4, randomised, double-blind trial of dexmedetomidine (2 arms), sponsored by Oulu University Hospital. Primary endpoint: Success of procedure at first attempt. Started Dec 2017; status: active.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2017-001297-41.